Roche makes lowered, hostile bid for Genentech (AP)

AP – Swiss pharmaceuticals company Roche Holding AG made a fresh bid to buy U.S.-based Genentech Inc. Friday by offering $86.50 per share — $2.50 less than its previous offer — directly to shareholders.

Leave a Reply